Refractory benign gastrointestinal stenosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) more than 20 years old 2) Those who have agreed in writing to participate in this clinical study 3) Patients who have no residual cancer (R0) for benign esophageal stenosis after surgery and endoscopic treatment (Confirmation has also been performed on CT, etc.) 4) Any post-operative reconstruction site and method 5) Dysphagia (Dysphagia score> 2) despite two or more sets of EBD (one set undergoes EBD more than once) with EBD as a pre-treatment for esophageal stenosis at least 1 month apart Patient with chief complaint. * Regardless of chemotherapy, PSL oral history
Exclusion criteria
Exclusion criteria: 1) Unable to obtain consent 2) When the length of the stenosis exceeds 11 mm or the preventive clip cannot be placed 3) Patients with mental illness or psychiatric symptoms who are judged to be difficult to conduct this clinical trial 4) Long axis stenosis length of 2 mm or more (confirmed by endoscopy and X-ray contrast) 5) Others who the doctor judged inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stenosis release rate [% of patients with improvement of dysphagia (up to Dysphagia score 1 or less), a subjective symptom at 24 weeks after the start of treatment (%): number of improved patients / total number of patients x100] | — |
Countries
Japan
Contacts
Faculty of Medicine, Kagawa University Hospital Investigator